Richard Ginn - 12 May 2022 Form 4 Insider Report for Tenon Medical, Inc. (TNON)

Role
Chief Technology Officer, Director
Signature
/s/ Richard Ginn
Issuer symbol
TNON
Transactions as of
12 May 2022
Net transactions value
$0
Form type
4
Filing time
16 May 2022, 17:30:39 UTC
Previous filing
26 Apr 2022
Next filing
24 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TNON Restricted Stock Unit 450,971 12 May 2022 COMMON STOCK 450,971 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Richard Ginn is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 These units are on a 3 year vesting schedule, for the first year they vest on an annual basis and thereafter they vest on a semi-annual basis.
F2 N/A